tiprankstipranks
Biophytis (BPTS)
NASDAQ:BPTS

Biophytis Stock Price & Analysis

8 Followers

BPTS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.56 - $8.54
Previous Close$0.6
Volume866.00
Average Volume (3M)174.39K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$5.21M
Total Debt (Recent Filing)$3.97M
P/E Ratio-0.2
Beta-0.09
Next EarningsOct 24, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-3.12
Shares Outstanding16,382,350
R-Squared0.00082
Standard Deviation0.14
10 Day Avg. Volume16,993
30 Day Avg. Volume174,386
P/B Ratio3.44
P/S RatioN/A
P/CF RatioN/A
P/FCF Ratio-0.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside2407.94% Upside
Rating ConsensusModerate Buy
Alpha-0.13
Number of Analyst Covering1


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

BPTS FAQ

What was Biophytis’s price range in the past 12 months?
Biophytis lowest stock price was $0.56 and its highest was $8.54 in the past 12 months.
    What is Biophytis’s market cap?
    Currently, no data Available
    When is Biophytis’s upcoming earnings report date?
    Biophytis’s upcoming earnings report date is Oct 24, 2022 which is in 21 days.
      How were Biophytis’s earnings last quarter?
      Biophytis released its earnings results on Feb 26, 2022. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.1 by -$0.01.
        Is Biophytis overvalued?
        According to Wall Street analysts Biophytis’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Biophytis pay dividends?
          Biophytis does not currently pay dividends.
          What is Biophytis’s EPS estimate?
          Biophytis’s EPS estimate is -$0.12.
            How many shares outstanding does Biophytis have?
            Biophytis has 20,067,572 shares outstanding.
              What happened to Biophytis’s price movement after its last earnings report?
              Biophytis reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.1. Following the earnings report the stock price went up 0.817%.
                Which hedge fund is a major shareholder of Biophytis?
                Currently, no hedge funds are holding shares in BPTS

                ---

                Biophytis Stock Analysis

                Smart ScoreNot Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                N/A
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Biophytis

                Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.

                ---
                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis